Nanobiotix

Nanobiotix is a nanomedicine company dedicated for the development of novel treatments and new therapeutics evolving based on the combined applications of nanotechnology and biotechnology for the local treatment of cancer. Nanobiotix researches and progresses biopharmaceutical medicine. Nanobiotix offers oncology nanomedicine treatments to control and treat cancer tumors. Bionanotechnology plays a critical role in both tissue engineering and drug delivery. Nanobiotix has improved a fresh class of therapeutics basing on nanoparticles and nanoxray therapeutics. They comprise of inert nanoparticles designed to enter in the tumor cells. They are injected straight through syringe into tumors, after stimulation by the standard dose of radiation, they relieve free radicals which destroys cancer cells. The lead product of the nanobiotix is NBTXR3 which is a radiosensitizer composed of hafnium oxide nanoparticles.

  • Nanosponges as drug delivery in cancer
  • Hafnium Oxide Nanoparticles(NBTXR3)
  • Polymer capsules as Nanoreactors for therapeutic applications
  • Study of NBTXR3 activated by radiation therapy
  • Nano X-ray technologies
  • NBTXR3 crystalline Nanoparticles

Related Conference of Nanobiotix

November 02-03, 2018

2nd International Conference on Nanostructured Materials & Nanochemistry

San Francisco | California | USA
November 26-28, 2018

3rd World Congress and Expo on Graphene & 2D Materials

Barcelona, Spain
February 21-22, 2019

22nd World Nanotechnology Congress

Abu Dhabi, UAE
May 20-21, 2019

30th World Nano Conference

Z├╝rich, Switzerland
March 21-22, 2019

24th Annual Meeting on Nanomaterials Science


New York | USA
Mar 25-26, 2019

21st Asia Pacific Nanotechnology Congress

Yokohama, Japan
August 29-31, 2019

31st Nano Congress for Future Advancements

London, UK
October 10-11, 2019

32nd International Conference on Advanced Nanotechnology

Dublin, Ireland

Nanobiotix Conference Speakers

Recommended Sessions

Related Journals

Are you interested in